Related references
Note: Only part of the references are listed.Spectrum of Clinicopathologic Findings in COVID-19-induced Skin Lesions Demonstration of Direct Viral Infection of the Endothelial Cells
Maria C. Garrido Ruiz et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic
Thomas Hubiche et al.
JAMA DERMATOLOGY (2021)
'Blue toes' following vaccination with the Pfizer BNT162b2 mRNA COVID-19 vaccine
Benjamin Davido et al.
JOURNAL OF TRAVEL MEDICINE (2021)
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
Kimberly G. Blumenthal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Improving cultural competency and practicing cultural humility in dermatologic training: Skin of color education and board certification
Trisha Kaundinya et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing
L. Le Cleach et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases
I. Colmenero et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Chilblain-like acral lesions during the COVID-19 pandemic (COVID): Histologic, immunofluorescence, and immunohistochemical study of 17 cases
Jean Kanitakis et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
COVID-19 and outbreak of chilblains: are they related?
C. Lesort et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)